<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-04970883</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-22T06:33:05+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Combining TNF-targeting antibodies to immune checkpoint inhibitors in melanoma</title>
            <author role="aut">
              <persName>
                <forename type="first">Anne</forename>
                <surname>Montfort</surname>
              </persName>
              <email type="md5">b435fd7b4533e97a31c6e8b7753f27e1</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">anne-montfort</idno>
              <idno type="idhal" notation="numeric">1491108</idno>
              <idno type="halauthorid" notation="string">452659-1491108</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-2926-4902</idno>
              <idno type="IDREF">https://www.idref.fr/158461061</idno>
              <affiliation ref="#struct-511697"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Florie</forename>
                <surname>Bertrand</surname>
              </persName>
              <idno type="halauthorid">1799017-0</idno>
              <affiliation ref="#struct-511697"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Elie</forename>
                <surname>Marcheteau</surname>
              </persName>
              <idno type="halauthorid">643857-0</idno>
              <affiliation ref="#struct-511697"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Caroline</forename>
                <surname>Imbert</surname>
              </persName>
              <idno type="idhal" notation="numeric">1427641</idno>
              <idno type="halauthorid" notation="string">717363-1427641</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-7946-6791</idno>
              <affiliation ref="#struct-179570"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Julia</forename>
                <surname>Gilhodes</surname>
              </persName>
              <email type="md5">90266cca66f83963c3597e18b7d0d6c8</email>
              <email type="domain">iuct-oncopole.fr</email>
              <idno type="idhal" notation="numeric">1091349</idno>
              <idno type="halauthorid" notation="string">1308705-1091349</idno>
              <affiliation ref="#struct-450027"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Philippe</forename>
                <surname>Rochaix</surname>
              </persName>
              <email type="md5">38c8f3561e773c3514310c837ac38851</email>
              <email type="domain">iuct-oncopole.fr</email>
              <idno type="idhal" notation="numeric">1513982</idno>
              <idno type="halauthorid" notation="string">166143-1513982</idno>
              <affiliation ref="#struct-511697"/>
              <affiliation ref="#struct-450027"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Thomas</forename>
                <surname>Filleron</surname>
              </persName>
              <email type="md5">9bb04f4c73c05d14f71d570604c00478</email>
              <email type="domain">claudiusregaud.fr</email>
              <idno type="idhal" notation="string">thomas-filleron</idno>
              <idno type="idhal" notation="numeric">768535</idno>
              <idno type="halauthorid" notation="string">686636-768535</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-0724-0659</idno>
              <idno type="IDREF">https://www.idref.fr/119887223</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=RBtpjz34B3kC</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/C-3554-2014</idno>
              <idno type="VIAF">https://viaf.org/viaf/192932239</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/C-3554-2014</idno>
              <affiliation ref="#struct-300150"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Maha</forename>
                <surname>Ayyoub</surname>
              </persName>
              <email type="md5">86197b9728b1cc5763ef321a4dcafb5e</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">maha-ayyoub</idno>
              <idno type="idhal" notation="numeric">773870</idno>
              <idno type="halauthorid" notation="string">906975-773870</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-2022-0898</idno>
              <affiliation ref="#struct-511697"/>
              <affiliation ref="#struct-300150"/>
              <affiliation ref="#struct-217752"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nathalie</forename>
                <surname>Andrieu-Abadie</surname>
              </persName>
              <email type="md5">37c661c4d3d42d07583be2538f824510</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">nathalie-andrieu-abadie</idno>
              <idno type="idhal" notation="numeric">758204</idno>
              <idno type="halauthorid" notation="string">213923-758204</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-2698-1970</idno>
              <idno type="IDREF">https://www.idref.fr/147902614</idno>
              <affiliation ref="#struct-511697"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Thierry</forename>
                <surname>Levade</surname>
              </persName>
              <email type="md5">c5aeb12da1c5966775c01608e61cd839</email>
              <email type="domain">toulouse.inserm.fr</email>
              <idno type="idhal" notation="numeric">1435751</idno>
              <idno type="halauthorid" notation="string">192850-1435751</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-3793-2584</idno>
              <affiliation ref="#struct-217752"/>
              <affiliation ref="#struct-511697"/>
              <affiliation ref="#struct-302158"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Céline</forename>
                <surname>Colacios</surname>
              </persName>
              <email type="md5">b796f1f0edac06041766a254bd6e4558</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">celine-colacios</idno>
              <idno type="idhal" notation="numeric">1065460</idno>
              <idno type="halauthorid" notation="string">227175-1065460</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-7509-0675</idno>
              <affiliation ref="#struct-511697"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nicolas</forename>
                <surname>Meyer</surname>
              </persName>
              <email type="md5">43129bb63564a03c1b67f3673aa6e528</email>
              <email type="domain">chu-toulouse.fr</email>
              <idno type="idhal" notation="numeric">1101781</idno>
              <idno type="halauthorid" notation="string">51955-1101781</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-4519-8666</idno>
              <idno type="IDREF">https://www.idref.fr/16890084X</idno>
              <affiliation ref="#struct-536848"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Bruno</forename>
                <surname>Ségui</surname>
              </persName>
              <email type="md5">843f54448783002df347ff1b10720344</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">bruno-segui</idno>
              <idno type="idhal" notation="numeric">868855</idno>
              <idno type="halauthorid" notation="string">230952-868855</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-6119-1889</idno>
              <affiliation ref="#struct-511697"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Anne</forename>
                <surname>Montfort</surname>
              </persName>
              <email type="md5">b435fd7b4533e97a31c6e8b7753f27e1</email>
              <email type="domain">inserm.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2025-02-28 10:39:26</date>
              <date type="whenModified">2026-02-07 05:30:30</date>
              <date type="whenReleased">2025-02-28 10:39:26</date>
              <date type="whenProduced">2018-02-03</date>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="536831">
                <persName>
                  <forename>Anne</forename>
                  <surname>Montfort</surname>
                </persName>
                <email type="md5">b435fd7b4533e97a31c6e8b7753f27e1</email>
                <email type="domain">inserm.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-04970883</idno>
            <idno type="halUri">https://hal.science/hal-04970883</idno>
            <idno type="halBibtex">montfort:hal-04970883</idno>
            <idno type="halRefHtml">&lt;i&gt;Toulouse Oncoweek&lt;/i&gt;, Feb 2018, Toulouse, France</idno>
            <idno type="halRef">Toulouse Oncoweek, Feb 2018, Toulouse, France</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-TLSE3">Université de Toulouse</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-AMU">Aix Marseille Université</idno>
            <idno type="stamp" n="CRCM">Centre de Recherche en Cancérologie de Marseille</idno>
            <idno type="stamp" n="UNIV-UT3">Université Toulouse 3</idno>
            <idno type="stamp" n="UT3-INP">Université de Toulouse / Toulouse INP</idno>
            <idno type="stamp" n="UT3-TOULOUSEINP">Université de Toulouse / Toulouse INP</idno>
            <idno type="stamp" n="CRCT">CRCT</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="invited" n="0">No</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
            <note type="proceedings" n="0">No</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Combining TNF-targeting antibodies to immune checkpoint inhibitors in melanoma</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Anne</forename>
                    <surname>Montfort</surname>
                  </persName>
                  <email type="md5">b435fd7b4533e97a31c6e8b7753f27e1</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">anne-montfort</idno>
                  <idno type="idhal" notation="numeric">1491108</idno>
                  <idno type="halauthorid" notation="string">452659-1491108</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-2926-4902</idno>
                  <idno type="IDREF">https://www.idref.fr/158461061</idno>
                  <affiliation ref="#struct-511697"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Florie</forename>
                    <surname>Bertrand</surname>
                  </persName>
                  <idno type="halauthorid">1799017-0</idno>
                  <affiliation ref="#struct-511697"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Elie</forename>
                    <surname>Marcheteau</surname>
                  </persName>
                  <idno type="halauthorid">643857-0</idno>
                  <affiliation ref="#struct-511697"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Caroline</forename>
                    <surname>Imbert</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">1427641</idno>
                  <idno type="halauthorid" notation="string">717363-1427641</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-7946-6791</idno>
                  <affiliation ref="#struct-179570"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Julia</forename>
                    <surname>Gilhodes</surname>
                  </persName>
                  <email type="md5">90266cca66f83963c3597e18b7d0d6c8</email>
                  <email type="domain">iuct-oncopole.fr</email>
                  <idno type="idhal" notation="numeric">1091349</idno>
                  <idno type="halauthorid" notation="string">1308705-1091349</idno>
                  <affiliation ref="#struct-450027"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Philippe</forename>
                    <surname>Rochaix</surname>
                  </persName>
                  <email type="md5">38c8f3561e773c3514310c837ac38851</email>
                  <email type="domain">iuct-oncopole.fr</email>
                  <idno type="idhal" notation="numeric">1513982</idno>
                  <idno type="halauthorid" notation="string">166143-1513982</idno>
                  <affiliation ref="#struct-511697"/>
                  <affiliation ref="#struct-450027"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Thomas</forename>
                    <surname>Filleron</surname>
                  </persName>
                  <email type="md5">9bb04f4c73c05d14f71d570604c00478</email>
                  <email type="domain">claudiusregaud.fr</email>
                  <idno type="idhal" notation="string">thomas-filleron</idno>
                  <idno type="idhal" notation="numeric">768535</idno>
                  <idno type="halauthorid" notation="string">686636-768535</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-0724-0659</idno>
                  <idno type="IDREF">https://www.idref.fr/119887223</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=RBtpjz34B3kC</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/C-3554-2014</idno>
                  <idno type="VIAF">https://viaf.org/viaf/192932239</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/C-3554-2014</idno>
                  <affiliation ref="#struct-300150"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Maha</forename>
                    <surname>Ayyoub</surname>
                  </persName>
                  <email type="md5">86197b9728b1cc5763ef321a4dcafb5e</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">maha-ayyoub</idno>
                  <idno type="idhal" notation="numeric">773870</idno>
                  <idno type="halauthorid" notation="string">906975-773870</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-2022-0898</idno>
                  <affiliation ref="#struct-511697"/>
                  <affiliation ref="#struct-300150"/>
                  <affiliation ref="#struct-217752"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nathalie</forename>
                    <surname>Andrieu-Abadie</surname>
                  </persName>
                  <email type="md5">37c661c4d3d42d07583be2538f824510</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">nathalie-andrieu-abadie</idno>
                  <idno type="idhal" notation="numeric">758204</idno>
                  <idno type="halauthorid" notation="string">213923-758204</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-2698-1970</idno>
                  <idno type="IDREF">https://www.idref.fr/147902614</idno>
                  <affiliation ref="#struct-511697"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Thierry</forename>
                    <surname>Levade</surname>
                  </persName>
                  <email type="md5">c5aeb12da1c5966775c01608e61cd839</email>
                  <email type="domain">toulouse.inserm.fr</email>
                  <idno type="idhal" notation="numeric">1435751</idno>
                  <idno type="halauthorid" notation="string">192850-1435751</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-3793-2584</idno>
                  <affiliation ref="#struct-217752"/>
                  <affiliation ref="#struct-511697"/>
                  <affiliation ref="#struct-302158"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Céline</forename>
                    <surname>Colacios</surname>
                  </persName>
                  <email type="md5">b796f1f0edac06041766a254bd6e4558</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">celine-colacios</idno>
                  <idno type="idhal" notation="numeric">1065460</idno>
                  <idno type="halauthorid" notation="string">227175-1065460</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-7509-0675</idno>
                  <affiliation ref="#struct-511697"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nicolas</forename>
                    <surname>Meyer</surname>
                  </persName>
                  <email type="md5">43129bb63564a03c1b67f3673aa6e528</email>
                  <email type="domain">chu-toulouse.fr</email>
                  <idno type="idhal" notation="numeric">1101781</idno>
                  <idno type="halauthorid" notation="string">51955-1101781</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-4519-8666</idno>
                  <idno type="IDREF">https://www.idref.fr/16890084X</idno>
                  <affiliation ref="#struct-536848"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Bruno</forename>
                    <surname>Ségui</surname>
                  </persName>
                  <email type="md5">843f54448783002df347ff1b10720344</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">bruno-segui</idno>
                  <idno type="idhal" notation="numeric">868855</idno>
                  <idno type="halauthorid" notation="string">230952-868855</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-6119-1889</idno>
                  <affiliation ref="#struct-511697"/>
                </author>
              </analytic>
              <monogr>
                <meeting>
                  <title>Toulouse Oncoweek</title>
                  <date type="start">2018-02-03</date>
                  <date type="end">2018-02-07</date>
                  <settlement>Toulouse</settlement>
                  <country key="FR">France</country>
                </meeting>
                <imprint/>
              </monogr>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">Melanoma, immunotherapy, TNF</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halDomain" n="sdv.imm">Life Sciences [q-bio]/Immunology</classCode>
              <classCode scheme="halDomain" n="sdv.imm.imm">Life Sciences [q-bio]/Immunology/Immunotherapy</classCode>
              <classCode scheme="halTypology" n="COMM">Conference papers</classCode>
              <classCode scheme="halOldTypology" n="COMM">Conference papers</classCode>
              <classCode scheme="halTreeTypology" n="COMM">Conference papers</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Purpose:Anti-PD-1 therapy has significantly improved the care of melanoma patients. However, more than 50% of them do not display optimal response to treatment and a significant proportion of responders relapse. In addition, about 50% of patients will experience mild to severe immune-related adverse events (irAEs). Our goal is to evaluate, both in pre-clinical and clinical settings, the impact of combining immune checkpoint inhibitors (ICI) to TNF blockade in the treatment of melanoma.Experimental Design:In pre-clinical analyses using the B16K1 (B16F10 MHC1high) mouse melanoma model we studied the impact of TNF deficiency /blockade on response to PD-1. The parameters assessed included tumor growth, overall survival (OS) of mice as well as analyses of the immune contexture of tumors1,2.Clinical analyses will be performed as a phase 1b clinical trial (TICIMEL: NCT03293784) assessing the safety and tolerance of combining ICI (Nivolumab + Ipilimumab) to anti-TNF (Infliximab or Certolizumab) for the treatment of metastatic melanoma patients. Results:Our pre-clinical studies demonstrated that blocking the TNF/TNFR1 pathway potentiates the CD8+ T cell-dependent anti-melanoma immune response in mouse. Moreover, blocking the TNF/TNFR1 pathway synergizes with anti-PD-1 treatment to impair tumor growth in mouse. In this context, anti-TNF prevent the anti-PD-1-dependent upregulation of TIM-3 on Tumor-infiltrating T cells as well as activation-induced cell death thus favoring CD8+ T cell accumulation in tumors1,2.Specifics of the clinical trial, which will begin by the end of 2017, will be presented.Conclusion:Our pre-clinical data support the use of TNF blocking antibodies to enhance response of melanoma patients to immune checkpoint inhibitors.   References :1Bertrand F et al. Blocking tumor necrosis factor alpha enhances CD8 T-cell-dependent immunity in experimental melanoma. (2015) Cancer Res., 75(13):2619-282Bertrand F. et al. TNF blockade overcomes PD-1 resistance in melanoma. Accepted at Nature Communications, November 2017.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-511697" status="OLD">
          <idno type="IdRef">168095661</idno>
          <idno type="ISNI">0000000477733907</idno>
          <idno type="RNSR">201119444S</idno>
          <idno type="ROR">https://ror.org/003412r28</idno>
          <orgName>Centre de Recherches en Cancérologie de Toulouse</orgName>
          <orgName type="acronym">CRCT</orgName>
          <date type="start">2011-01-01</date>
          <date type="end">2025-01-01</date>
          <desc>
            <address>
              <addrLine>Centre de Recherches en Cancérologie de Toulouse2 Avenue Hubert Curien31037 Toulouse Cedex 1FRANCE</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.crct-inserm.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-217752" type="direct"/>
            <relation active="#struct-443875" type="indirect"/>
            <relation name="U1037" active="#struct-303623" type="direct"/>
            <relation name="UMR5071 / ERL5294" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-179570" status="VALID">
          <idno type="RNSR">201220152G</idno>
          <idno type="ROR">0494jpz02</idno>
          <orgName>Centre de Recherche en Cancérologie de Marseille</orgName>
          <orgName type="acronym">CRCM</orgName>
          <date type="start">2012</date>
          <desc>
            <address>
              <addrLine>27 bd Leï Roure, BP 30005913273 Marseille Cedex 09</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://crcm.marseille.inserm.fr/spip.php?article314</ref>
          </desc>
          <listRelation>
            <relation name="UM105" active="#struct-198056" type="direct"/>
            <relation name="UMR7258" active="#struct-301325" type="direct"/>
            <relation active="#struct-301051" type="indirect"/>
            <relation name="U1068" active="#struct-303623" type="direct"/>
            <relation name="UMR7258" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="regrouplaboratory" xml:id="struct-450027" status="OLD">
          <idno type="ROR">https://ror.org/014hxhm89</idno>
          <orgName>Institut Universitaire du Cancer de Toulouse - Oncopole</orgName>
          <orgName type="acronym">IUCT Oncopole - UMR 1037</orgName>
          <desc>
            <address>
              <addrLine>Av. Irène Joliot-Curie 31100 Toulouse</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-217752" type="direct"/>
            <relation active="#struct-443875" type="indirect"/>
            <relation active="#struct-300075" type="direct"/>
            <relation active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300150" status="VALID">
          <orgName>Oncopole Claudius Regaud</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-1673976" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-217752" status="OLD">
          <idno type="IdRef">026404672</idno>
          <idno type="ISNI">0000000121617331</idno>
          <idno type="ROR">https://ror.org/02v6kpv12</idno>
          <idno type="Wikidata">Q1273188</idno>
          <orgName>Université Toulouse III - Paul Sabatier</orgName>
          <orgName type="acronym">UT3</orgName>
          <date type="end">2025-01-01</date>
          <desc>
            <address>
              <addrLine>118 route de Narbonne - 31062 Toulouse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-tlse3.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-443875" type="direct"/>
          </listRelation>
        </org>
        <org type="regrouplaboratory" xml:id="struct-302158" status="VALID">
          <orgName>Institut Fédératif de Biologie (IFB)</orgName>
          <desc>
            <address>
              <addrLine>Hôpital Purpan, 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-300075" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-536848" status="VALID">
          <orgName>Service Dermatologie [CHU Toulouse]</orgName>
          <desc>
            <address>
              <addrLine>Hôpital Larrey, 24, chemin de Pouvourville - TSA 30030 - 31059 Toulouse cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-toulouse.fr/-dermatologie-</ref>
          </desc>
          <listRelation>
            <relation active="#struct-1152912" type="direct"/>
            <relation active="#struct-300075" type="indirect"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-443875" status="VALID">
          <idno type="ROR">https://ror.org/017tgbk05</idno>
          <orgName>Communauté d'universités et établissements de Toulouse</orgName>
          <orgName type="acronym">Comue de Toulouse</orgName>
          <desc>
            <address>
              <addrLine>41 Allée Jules Guesde, 31000 Toulouse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-toulouse.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-198056" status="VALID">
          <idno type="IdRef">15863621X</idno>
          <idno type="ISNI">0000 0001 2176 4817</idno>
          <idno type="ROR">https://ror.org/035xkbk20</idno>
          <orgName>Aix Marseille Université</orgName>
          <orgName type="acronym">AMU</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>Aix-Marseille UniversitéJardins du Pharo58 Boulevard Charles Livon13284 Marseille cedex 7</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-amu.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-301325" status="VALID">
          <idno type="ROR">https://ror.org/04s3t1g37</idno>
          <orgName>Institut Paoli-Calmettes</orgName>
          <orgName type="acronym">IPC</orgName>
          <desc>
            <address>
              <addrLine>232 Boulevard de Sainte-Marguerite13009 Marseille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.institutpaolicalmettes.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301051" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-301051" status="VALID">
          <orgName>Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300075" status="VALID">
          <orgName>Centre Hospitalier Universitaire de Toulouse</orgName>
          <orgName type="acronym">CHU Toulouse</orgName>
          <desc>
            <address>
              <addrLine>regroupe les hôpitaux  Purpan, Rangueil, Pierre-Paul Riquet, Larey, Paule de Viguier, Hôtel Dieu Saint-Jacques, La Grave, etc.</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-toulouse.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-1673976" status="VALID">
          <orgName>IUCT Oncopole</orgName>
          <desc>
            <address>
              <addrLine>Av. Irène Joliot-Curie 31100 Toulouse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.iuct-oncopole.fr</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-1152912" status="VALID">
          <orgName>Pôle Clinique des Voies respiratoires [CHU Toulouse]</orgName>
          <desc>
            <address>
              <addrLine>Toulouse</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-300075" type="direct"/>
          </listRelation>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>